Literature DB >> 20460637

Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.

Caterina Cancrini1, Francesca Ferrua, Alessia Scarselli, Immacolata Brigida, Maria Luisa Romiti, Graziano Barera, Andrea Finocchi, Maria Grazia Roncarolo, Maurizio Caniglia, Alessandro Aiuti.   

Abstract

The treatment of choice for severe combined immunodeficiency is bone marrow transplantation from an HLA-identical donor sibling without conditioning. However, this may result in low donor stem cell chimerism, leading to reduced long-term immune reconstitution. We compared engraftment, metabolic, and T-cell and B-cell immune reconstitution of HLA-identical sibling bone marrow transplantation performed in 2 severe combined immunodeficiency infants with adenosine deaminase deficiency from the same family treated with or without a reduced intensity conditioning regimen (busulfan/fludarabine). Only the patient who received conditioning showed a stable mixed chimerism in all lineages, including bone marrow myeloid and B cells. The use of conditioning resulted in higher thymus-derived naïve T cells and T-cell receptor excision circles, normalization of the T-cell repertoire, and faster and complete B-cell and metabolic reconstitution. These results suggest the utility of exploring the use of reduced intensity conditioning in bone marrow transplantation from HLA-identical donor in severe combined immunodeficiency to improve long-term immune reconstitution.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460637      PMCID: PMC2948105          DOI: 10.3324/haematol.2010.025098

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  23 in total

1.  Reduced intensity transplantation for primary immunodeficiency disorders.

Authors:  Paul Veys
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

2.  Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.

Authors:  M H Rogers; R Lwin; L Fairbanks; B Gerritsen; H B Gaspar
Journal:  J Pediatr       Date:  2001-07       Impact factor: 4.406

3.  Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.

Authors:  W M Comans-Bitter; R de Groot; R van den Beemd; H J Neijens; W C Hop; K Groeneveld; H Hooijkaas; J J van Dongen
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

4.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.

Authors:  S Slavin; A Nagler; E Naparstek; Y Kapelushnik; M Aker; G Cividalli; G Varadi; M Kirschbaum; A Ackerstein; S Samuel; A Amar; C Brautbar; O Ben-Tal; A Eldor; R Or
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

5.  Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.

Authors:  C J Wu; A Chillemi; E P Alyea; E Orsini; D Neuberg; R J Soiffer; J Ritz
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

6.  T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.

Authors:  Marcella Sarzotti; Dhavalkumar D Patel; Xiaojing Li; Daniel A Ozaki; Shui Cao; Scott Langdon; Roberta E Parrott; Katherine Coyne; Rebecca H Buckley
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients.

Authors:  E Haddad; F Le Deist; P Aucouturier; M Cavazzana-Calvo; S Blanche; G De Saint Basile; A Fischer
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

Review 8.  Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.

Authors:  M S Hershfield
Journal:  Semin Hematol       Date:  1998-10       Impact factor: 3.851

9.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  9 in total

Review 1.  Stem Cells, Hematopoiesis and Lineage Tracing: Transplantation-Centric Views and Beyond.

Authors:  Anna Konturek-Ciesla; David Bryder
Journal:  Front Cell Dev Biol       Date:  2022-04-27

Review 2.  Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4.

Authors:  A Casrouge; A V Sauer; R Barreira da Silva; M Tejera-Alhambra; S Sánchez-Ramón; C Cancrini; M A Ingersoll; A Aiuti; M L Albert
Journal:  Clin Exp Immunol       Date:  2018-09-24       Impact factor: 4.330

Review 3.  Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.

Authors:  Donald B Kohn; Michael S Hershfield; Jennifer M Puck; Alessandro Aiuti; Annaliesse Blincoe; H Bobby Gaspar; Luigi D Notarangelo; Eyal Grunebaum
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793

4.  Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.

Authors:  Alessia Scarselli; Silvia Di Cesare; Claudia Capponi; Simona Cascioli; Maria L Romiti; Gigliola Di Matteo; Alessandra Simonetti; Paolo Palma; Andrea Finocchi; Barbarella Lucarelli; Rita M Pinto; Ippolita Rana; Giuseppe Palumbo; Maurizio Caniglia; Paolo Rossi; Rita Carsetti; Caterina Cancrini; Alessandro Aiuti
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

5.  B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.

Authors:  Immacolata Brigida; Aisha V Sauer; Francesca Ferrua; Stefania Giannelli; Samantha Scaramuzza; Valentina Pistoia; Maria Carmina Castiello; Barbara H Barendregt; Maria Pia Cicalese; Miriam Casiraghi; Chiara Brombin; Jennifer Puck; Klaus Müller; Lucia Dora Notarangelo; Davide Montin; Joris M van Montfrans; Maria Grazia Roncarolo; Elisabetta Traggiai; Jacques J M van Dongen; Mirjam van der Burg; Alessandro Aiuti
Journal:  J Allergy Clin Immunol       Date:  2014-02-05       Impact factor: 10.793

6.  In vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog model.

Authors:  J L Gori; B C Beard; C Ironside; G Karponi; H-P Kiem
Journal:  Cancer Gene Ther       Date:  2012-05-25       Impact factor: 5.987

7.  Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.

Authors:  Aisha Vanessa Sauer; Immacolata Brigida; Nicola Carriglio; Alessandro Aiuti
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

8.  Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.

Authors:  Maria Pia Cicalese; Francesca Ferrua; Laura Castagnaro; Katie Rolfe; Erika De Boever; Rickey R Reinhardt; Jonathan Appleby; Maria Grazia Roncarolo; Alessandro Aiuti
Journal:  Mol Ther       Date:  2018-01-04       Impact factor: 11.454

9.  Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience.

Authors:  H Bobby Gaspar; Claire Booth; Alexandra Y Kreins; Helena F Velasco; Kai-Ning Cheong; Kanchan Rao; Paul Veys; Austen Worth
Journal:  J Clin Immunol       Date:  2021-10-16       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.